시장진입을 위한 치료재료 신의료기술평가 제도: 의료법, 의료기기법, 국민건강보험법 중심으로
New Health Technology Assessment for Market Access of Medical Device in Korea: Review of Medical Law, Medical Device Law, National Health Insurance Law
2
조회
0
다운로드
0
인용
0
참고문헌
초록
The “New Health Technology Assessment” system for new health technology was first introduced in 2007 in Korea and there have been some gradual changes and improvements. The Health Tech- nology Assessment (HTA) is a process that is being implemented in major countries across Europe as well as Korea through which the safety and effectiveness of new health technology is evaluated using a systematic review methodology. Despite the fact that HTA is focused on assessment of tech- nology, rather than on individual medical devices, treatments are mostly caused by those newly-de- veloped medical devices. Accordingly, even if it’s an assessment on health technology, clinical evi- dence is for medical devices used in this technology. HTA is different from the point of view product approval that verifies safety and effectiveness of the product itself, since it assesses safety and effectiveness on health outcomes when the treatment with a medical device is operated for the patient. However, considering the opinion that the reimbursement application process of medical service for the right of access to health insurance circle needs a long period and has to take compli- cated procedures compared to the product approval by the Ministry of Food and Drug Safety (MFDS), there have been various adjustments to improve the process since 2013. Including the most recently implemented “MFDS product approval-HTA parallel review” system, there are five tracks for HTA as of present. It is essential that the applicant applying for nHTA should review the relevant provisions on the Medical Law, Medical Device Law and National Health Insurance Law for accurate understanding of the system and needs to make an effort to prepare materials suitable for the objective. The purpose of this review is to discuss the purpose and objective of current nHTA in Korea, to review similar process of other countries and to introduce relevant administrative pro- cess according to relevant laws to suggest further necessary improvements of the system.
Abstract
The “New Health Technology Assessment” system for new health technology was first introduced in 2007 in Korea and there have been some gradual changes and improvements. The Health Tech- nology Assessment (HTA) is a process that is being implemented in major countries across Europe as well as Korea through which the safety and effectiveness of new health technology is evaluated using a systematic review methodology. Despite the fact that HTA is focused on assessment of tech- nology, rather than on individual medical devices, treatments are mostly caused by those newly-de- veloped medical devices. Accordingly, even if it’s an assessment on health technology, clinical evi- dence is for medical devices used in this technology. HTA is different from the point of view product approval that verifies safety and effectiveness of the product itself, since it assesses safety and effectiveness on health outcomes when the treatment with a medical device is operated for the patient. However, considering the opinion that the reimbursement application process of medical service for the right of access to health insurance circle needs a long period and has to take compli- cated procedures compared to the product approval by the Ministry of Food and Drug Safety (MFDS), there have been various adjustments to improve the process since 2013. Including the most recently implemented “MFDS product approval-HTA parallel review” system, there are five tracks for HTA as of present. It is essential that the applicant applying for nHTA should review the relevant provisions on the Medical Law, Medical Device Law and National Health Insurance Law for accurate understanding of the system and needs to make an effort to prepare materials suitable for the objective. The purpose of this review is to discuss the purpose and objective of current nHTA in Korea, to review similar process of other countries and to introduce relevant administrative pro- cess according to relevant laws to suggest further necessary improvements of the system.
참고문헌 (26)
- 신의료기술 평가제도 발전방안 연구, "안정훈", 한국보건의료연구원, 1~105 (2012)
- "New Health Technology Assessment"[URL]
- adjustment, "Ministry of Health and Welfare public notice number 2016-84", 2016
- Jun OC, "The definition and present status of new health technology", Korean J Clin Oncol, 4, pp.4~15 (2008)
- 이원영, "영국 NICE 의료기술평가의 환자 및 시민참여 경험에 대한 고찰", 비판사회정책, (34), pp.47~75 (2012), 비판과대안을위한사회복지학회[DOI]
- Choi JE, , Social Utilization of HTA-2015 Report of the 3rd NECA annual conference (2015), National Evidence-based Healthcare Collaborating Agency
- Study on Evidence-based reimbursement decision of medical devices: Guideline on Cost-effectiveness assessment, "Review and Assessment Center of Health Insurance Review & Assessment Service", ~ (2015)
- Schmitz S, "Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment : A Retrospective Analysis of Reimbursement Recommendations in Ireland", Pharmacoeconomics, 34, pp.925~937 (2016)
- 이상수, "의료기술개발 및 국제화: 산업체의 역할", 대한의사협회지, 57(11), pp.919~926 (2014), 대한의사협회[DOI]
- "Status of limited health technology assessment"[URL]
- "Presentation on the policy of expanding the limited health technology assessment"[URL]
- "Ministry of Health and Welfare public notice number 2016-144 (MFDS approval-HTA parallel review management) effective from 2016.7.29", ~ (2016)
- National Law Information Center, "Regulation on Health Technology Assessment number 2 (Subject of Health Technology Assessment)", ~
- [URL]
- Husereau D, "Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devices", Int J Technol Assess Health Care, 30, pp.241~249 (2014)
- adjustment, "Ministry of Health and Welfare public notice number 2016-150. Safety and Effectiveness evaluation result of new Health Technology", List of safe and effective technologies evaluated, ~
- 이민, "한국 의료기술평가의 현황과 문제점 그리고 개선책", 대한의사협회지, 57(11), pp.906~911 (2014), 대한의사협회[DOI]
- "A Review of NICE Methods Across Health Technology Assessment Programmes: Differences" (2016)[URL]
- National Law Center, "Standards of Decision and Adjustment of Service and Device", ~
- Chun SI, "Study on Reimbuursement Pricing Calculation of Therapeutic Materials. Methodological review of reimbursement system of therapeutic materials of other countries", Master, pp.2013
- Comparative study on the health technology assessment systems of major countries, "Kim SY", National Evidence-based Healthcare Collaborating Agency, ~ (2014)
- Regulation of Health Technology Assessment, "National Law Information Center", Ministry of Health and Welfare, ~ (2015)
- National Law Information Center, "Regulation on MFDS License-HTA Parallel Review Process", MOHW Public notice 2016-144, ~ (2016)
- National Law Information Center, "Standards of Decision and Adjustment of Service and Device", MOHW public notice number 2010-82, ~ (2010)